DUBLIN, IRELAND--(Marketwired - Mar 25, 2014) - 'Investment-In-Innovation (IN3) Medical Device 360° Dublin,' the medtech industry's leading partnering event is only two weeks away in Dublin, Ireland, April 8-10, 2014 at The Shelbourne Dublin. This special event will bring together a diverse group of medtech's key thought leaders including corporate business development execs, venture capital and angel investors, and start-up entrepreneurs and will feature an outstanding agenda of panels, networking sessions and meet-and-greets with industry thought.
Join us for two Keynote Leadership Fireside Chats on Tuesday, April 8th at 10:30 AM, "The Art of Innovation - Inventing, Financing and leading New Medical Device Companies" with Hanson S. Gifford, III, Partner, and Mark Deem, Managing Partner, of The Foundry and on Wednesday, April 9th at 1:00 PM, "Advancing Disruptive Medical Technologies" with Mark Gelfand, Partner, Coridea Inc.
An unprecedented number of dealmakers are partnering at IN3 Dublin including: Abingworth Management Ltd., ACT, Aerogen, Apposite Capital, Bank of Ireland, Baxter International Inc., Bay City Capital Partners, LLC, Boston Scientific Corporation, Cook Medical, Inc., Coridea, Covidien Ltd., Covington Associates, Creganna Medical Devices, Delta Partners, Earlybird Venture Capital, Edmond de Rothschild Investment Partners, Edwards Lifesciences LLC, Endeavour Vision, Enterprise Equity Venture Capital, Enterprise Ireland, Entrepreneurs Fund, European Investment Fund, Forbion Capital, Fountain Healthcare Partners, Glide Healthcare Partners, i360, IMB Venture Capital, Johnson & Johnson, JP Morgan, Lightstone Ventures, LSP Health Economics Fund, Medtronic, MVM Life Science Partners, Omnes Capital, Peppermint Venture Partners, RCT BioVentures, Seroba Kernel Life Sciences, Seventure Partners, Sofinnova Ventures, Inc., Soring Group, Sunstone, The Foundry, Inc. The Trendlines Group, Venture Incubator AG, XMS Capital, and Ysios Capital Partners.
Feature presentations by 30+ early-, mid- and late-stage start-up companies seeking funding and/or strategic partnership. Presenting companies to date include Aerogen, Inc., Anagnostics Bioanalysis GmbH, Autonomic Technologies Inc., Capsos Medical, Defymed, Dimicron, Inc., DMF Medical, Inc., Embo Medical, Emperra, Functional Neuromodulation, Inc., Human.technology Styria GmbH, Humedics GmbH, Implandata Ophthalmic Products GmbH, Kalamar Technologies Ltd., Keystone Heart Ltd., Licensale Inc, LIM Innovations, Miracor Medical Systems GmbH, Nasseo, Inc., Neuravi Ltd., Novate Medical Ltd., PQ Bypass, Quanta Fluid Solutions, Seiratherm GmbH, Senzime, Symptoma / Click for Knowledge GmbH, ThermopeutiX, Inc., Transcatheter Technologies GMGH, Veryan Medical, Ltd., Zydacron, and Zyomyx, Inc. Emerging medtech companies that would like to apply to present in Dublin should contact Kayleen Kell at email@example.com.
KPMG and Enterprise Ireland would like to invite attendees on a special trip to Galway on Monday, April 7th. Galway is one of Europe's leading medtech clusters with a large presence of multinational and Irish companies, as well as research institutes. For the agenda or to register, please visit http://pages.pharmamedtechbi.net/IN3Dublin14-GalwayTrip/.
Event sponsors include Enterprise Ireland, Seroba Kernel, KPMG, Medmarc, Eugene F. Collins, Bank of Ireland, Creganna Tactx Medical, XMS Capital Partners, Medpace, PEI, Eucomed, Marketwired, MassMEDIC and OneMedPlace.
Visit www.in3dublin.com for full conference and registration details.
About IN3 Medical Device 360° Conferences
Investment-In-Innovation (IN3) Medical Device 360° Conferences, hosted by Informa, have been regarded as one of the most exceptional medical device partnering events for the past 14 years. The conferences highlight early-to late state companies looking to meet and network with potential investors from the healthcare investment firms, to larger top-tier medical device companies for the purpose of funding, M&A, or strategic partnership. International industry experts discuss the most pressing issues during a variety of financing, business development, clinical/regulatory, reimbursement and emerging market panel discussions, presentations and networking sessions.